[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[diphenhydramine] |
3.70 |
|
|
23.0 |
phase solubility |
Pascal Le Corre 1998 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[diphenhydramine] |
2.95 |
|
|
37.0 |
phase solubility |
Pascal Le Corre 1998 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Ebselen] |
3.00 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[N-(1-adamantylmethyl)-] |
4.04 |
3.00 |
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[N-octyl-] |
2.81 |
1.70 |
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[N-(4-tert-butyl benzyl)-] |
3.72 |
2.48 |
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[[1-(3,4-dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline]] |
1.99 |
0.05 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[{(+)-(3S,4R)-3-ethyl-4-[(1-methyl.5-imidazolyl)-metyl]-tetrahydrofuran-2-on}] |
2.02 |
0.03 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[[(−)-(8S,9R)-6'-methoxy-cinchonanol]] |
3.10 |
0.05 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[ursodeoxycholic acid] |
3.63 |
|
7.4 |
24.0 |
HPLC-method |
G. Puglisi 1997 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[ursodeoxycholic acid] |
3.28 |
|
7.4 |
37.0 |
HPLC-method |
G. Puglisi 1997 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[ursodeoxycholic acid] |
2.80 |
|
7.4 |
45.0 |
HPLC-method |
G. Puglisi 1997 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[chenodeoxycholic acid] |
2.75 |
|
7.4 |
25.0 |
HPLC-method |
G. Puglisi 1997 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[sodium a,w-octyl dicarboxylate] |
1.94 |
1.59 |
10.5 |
25.0 |
Apparent molar volume measurements |
Ronald E. Verrall 2000 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[sodium a,w-decanyl dicarboxylate] |
2.99 |
2.34 |
10.5 |
25.0 |
Apparent molar volume measurements |
Ronald E. Verrall 2000 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[sodium a,w-dodecyl dicarboxylate] |
3.34 |
2.91 |
10.5 |
25.0 |
Apparent molar volume measurements |
Ronald E. Verrall 2000 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[harmane] |
2.06 |
1.62 |
7.8 |
22.0 |
Fluorescence spectroscopy |
B. del Castillo 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[harmine] |
2.05 |
1.34 |
7.8 |
22.0 |
Fluorescence spectroscopy |
B. del Castillo 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin B1] |
2.95 |
1.96 |
7.0 |
|
Fluorescence spectroscopy |
Rosangela Marchelli 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin G1] |
2.89 |
1.94 |
7.0 |
|
Fluorescence spectroscopy |
Rosangela Marchelli 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin M3] |
2.74 |
1.79 |
7.0 |
|
Fluorescence spectroscopy |
Rosangela Marchelli 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin B2] |
2.56 |
1.82 |
7.0 |
|
Fluorescence spectroscopy |
Rosangela Marchelli 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin G2] |
2.76 |
1.75 |
7.0 |
|
Fluorescence spectroscopy |
Rosangela Marchelli 2003 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[5,10,15-tris(3,5-dicarboxylatophenyl)-20-phenylporphyrin] |
4.08 |
3.00 |
7.0 |
25.0 |
Isothermal titration calorimetry |
Koji Kano 2005 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[[(−)-(5R,6S)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol]] |
2.44 |
0.05 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[{DL-endo-(-hydroxybenzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester}] |
3.30 |
0.10 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |